French court finds German firm liable in implants scandal (Update)

November 14, 2013 by Hugues Jeanneaud

A French court on Thursday found German safety standards firm TUV liable in a worldwide scare over defective breast implants and ordered the company to compensate distributors and hundreds of victims.

The court in the southern city of Toulon ruled that TUV Rheinland had "neglected its duties of checking and vigilance" after having certified that implants made by French firm Poly Implant Prothese (PIP) conformed to safety rules—even though they were subsequently found to contain substandard, industrial-grade silicone gel.

The scandal first emerged in 2010 after doctors noticed abnormally high rupture rates in PIP implants and gathered steam worldwide in 2011, with some 300,000 women in 65 countries believed to have received the faulty implants.

Six distributors of the implants from Bulgaria, Brazil, Italy, Syria, Mexico and Romania sued TUV for a total of 28 million euros ($38 million).

Nearly 1,700 women who were fitted with the implants—most of them from South America but also from France and Britain—also asked the German firm for 16,000 euros each, taking the total claims against TUV to 53 million euros.

The court ordered the German firm to compensate "the damage (done to) importers and victims", telling TUV to give them 3,000 euros each while waiting for individual medical or financial assessments to be conducted on each plaintiff.

Only when these assessments are finished will TUV know the exact sum to be paid out.

More than 16,000 women have had the implants removed since the scandal came to light, but health officials in various countries estimate they are not toxic and are not thought to increase the risk of breast cancer.

Civil proceedings against TUV took place in March, and came on top of a high-profile criminal court case in April and May in the nearby city of Marseille against PIP founder Jean-Claude Mas and four other executives.

All five are charged with aggravated fraud and a ruling on that case is expected on December 10.

In the TUV case, lawyers for the distributors and victims had condemned the German firm for not ever having checked the implants despite all the means at their disposal, such as unannounced inspections or sample testing.

But lawyers for TUV retorted that it was never the German firm's job to check the actual implants, and their task was only to inspect the manufacturing process.

Cecile Derycke, who was defending TUV, said the company was "shocked by the judgment" and had decided to appeal.

"TUV had strictly conformed to the regulations in force," she said.

The case prompted the European Commission to set out new rules in September saying inspection bodies will now have to randomly carry out unannounced factory audits and check for the substitution or adulteration of raw materials.

Mas, a former life-insurance salesman, founded PIP in 1991 to take advantage of the boom in cosmetic implants and built the company into the third-largest global supplier.

But he came under the spotlight when plastic surgeons began reporting an unusual number of ruptures in his products, and health authorities later discovered he was saving millions of euros by using the industrial-grade gel in 75 percent of the implants.

PIP—which has since been liquidated—had exported more than 80 percent of its implants, with about half going to Latin America, about a third to other countries in western Europe, about 10 percent to eastern Europe and the rest to the Middle East and Asia.

Explore further: German firm on trial over faulty French breast implants

Related Stories

German firm on trial over faulty French breast implants

March 22, 2013
Proceedings against a German safety standards firm that gave defective breast implants the all clear kicked off Friday in France, with millions of euros claimed in damages.

Women in Argentina sue for $54 mn over faulty implants

August 26, 2013
About 300 women with faulty PIP breast implants have filed suit seeking $54.7 million in damages from three European companies, their attorney said Monday.

Hundreds expected for French breast implants mega-trial

April 15, 2013
France will launch one its biggest-ever trials on Wednesday as five managers from company PIP face charges of selling faulty breast implants that sparked a global health scare.

Breast implant scare: One in four found flawed

June 25, 2013
Doctors in France have removed PIP breast implants from more than 16,000 women and found a quarter of the scandal-tainted products had signs of splitting or leakage, a watchdog said on Tuesday.

French executives on trial over faulty breast implants (Update)

April 17, 2013
France launched one of its biggest-ever trials on Wednesday as five managers from company PIP faced charges of selling faulty breast implants that sparked a global health scare.

Some 8,000 French women have faulty breast implants removed

June 4, 2012
French health authorities said Monday that nearly 8,000 French women had followed a government recommendation to have faulty breast implants that sparked a global health scare removed.

Recommended for you

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

Best of Last Year – The top Medical Xpress articles of 2016

December 23, 2016
(Medical Xpress)—It was a big year for research involving overall health issues, starting with a team led by researchers at the UNC School of Medicine and the National Institutes of Health who unearthed more evidence that ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.